Table of Contents Table of Contents
Previous Page  17 / 60 Next Page
Information
Show Menu
Previous Page 17 / 60 Next Page
Page Background

15

PROGRAMME & EXHIBITION GUIDE |

SCIENTIFIC PROGRAMME

Proffered papers

HIGHLIGHTS OF PROFFERED PAPERS

08:30 - 09:00

Chair: R. Brakenhoff (The Netherlands)

08:30 Molecular screening for cancer treatment optimisation in head and neck

cancer (MOSCATO 01)

C. Even (France), I. Breuskin, E. Ileana, C. Massard, L. Lacroix, N. Lezghed, J.

Guigay, F. Janot, J.C. Soria, C. Ferté

OC-014

08:40 Therapeutic HPV vaccine increases sensitivity of poorly immunogenic

tumour to anti-PD-1 monotherapy

S. Pai (USA), D. Smith, S. Peng, E. Ishida, B. Akpeng, C.F. Hung, T.C. Wu

OC-015

08:50 Patient reported outcomes (PRO) of RTOG 9003

A. Konski (USA), Z. Qiang, K.K. Ang, K.K. Fu, A. Trotti, S. Spencer, B. Gunn,

G. Shenouda, Q. Le

OC-016

Proffered papers

SESSION 1

09:00 - 10:00

Chair: S. Hosal (Turkey)

Chair: J. Giralt (Spain)

09:00 Refining UICC TNM stage and prognostic groups for non-metastatic

HPV-related oropharyngeal carcinomas

B. O’Sullivan (Canada), S. Huang, J. Waldron, A. Bayley, J. Kim, A. Hope,

J. Ringash, J. Cho, M. Giuliani, W. Xu

OC-017

09:10 GORTEC randomised trial evaluating OTD70DERM on dermatitis in head

and neck cancer undergoing RT cetuximab

Y. Tao (France), A. Auperin, C. Sire, M. Martin, M.G. Saliou, E. Bardet,

X. Sun, C. Morand, I. D’Onofrio, J. Bourhis

OC-018

09:20 Salvage surgery after head and neck squamous cell carcinoma treated with

bioradiotherapy

A. Rovira Casas (Spain), J. Tornero, M. Oliva, M. Taberna, J. Nogues,

V. Navarro-Perez, J. Viñals, A. Mari, A. Lozano, M. Maños

OC-019

FRIDAY 13 FEBRUARY 2015